Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Accounts Payables (2023 - 2025)

Upstream Bio (UPB) has 3 years of Accounts Payables data on record, last reported at $4.0 million in Q3 2025.

  • For Q3 2025, Accounts Payables fell 19.33% year-over-year to $4.0 million; the TTM value through Sep 2025 reached $4.0 million, down 19.33%, while the annual FY2024 figure was $4.0 million, 103.07% up from the prior year.
  • Accounts Payables reached $4.0 million in Q3 2025 per UPB's latest filing, up from $2.6 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $4.9 million in Q3 2024 and bottomed at $2.0 million in Q4 2023.
  • Average Accounts Payables over 3 years is $3.7 million, with a median of $4.0 million recorded in 2024.
  • Peak YoY movement for Accounts Payables: surged 103.07% in 2024, then fell 19.33% in 2025.
  • A 3-year view of Accounts Payables shows it stood at $2.0 million in 2023, then skyrocketed by 103.07% to $4.0 million in 2024, then fell by 2.2% to $4.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accounts Payables were $4.0 million in Q3 2025, $2.6 million in Q2 2025, and $4.7 million in Q1 2025.